ChemoCentryx

Develops orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.

HQ location

San Carlos, United States

Website

chemocentryx.com

Launch date

1997

Employees

Market cap

Enterprise value

$3.5b

Share price

$51.99 CCXI

https://twitter.com/chemocentryxinc http://www.facebook.com/pages/Chemocentryx/168142206536222 https://www.linkedin.com/company/chemocentryx/

Authorizing premium user...